Microchip Biotechnologies Licenses Technology for Developing Microfluidic Devices
News Aug 24, 2007
Microchip Biotechnologies, Inc. (MBI) and TEC Edmonton have entered into an exclusive patent license agreement that allows MBI to commercialize a University of Alberta invention that can improve the development of lab-on-a-chip devices and biosampling procedures.
“The licensing of this fundamental patent on manipulating beads on-chip continues to build upon our strong intellectual property position in microfluidic devices,” said Stevan Jovanovich, President and CEO of MBI.
“Microfluidic devices will play a critical role in next generation instrumentation in delivering fully automated, cost effective solutions life science, applied sciences, and diagnostic products for laboratory and field based applications,” he added.
California-based MBI will use the technology patented by TEC Edmonton officially called an Apparatus and Method for Trapping Bead Based Reagents within Microfluidic Analysis Systems (US Patent 6,432,290).
A team led by Dr. Jed Harrison, Professor and Chair in the Department of Chemistry, invented the technology to allow trapping of beads on-chip, as well as packing and unpacking the trapping zones, which significantly extends the applications of microfluidic analysis systems, such as those used in biodefense and genomics industries.
Bubble formation is typically a much more random process than liquid droplet formation, yet the generation of uniform drops and bubbles is very desirable in microfluidics. Researchers have now shown that under certain conditions, bubbles can also be coaxed to form spheres as perfectly matched as droplets.READ MORE